On June 15, 2014, the fourth subject was treated in our ongoing Israeli study of MDMA-assisted psychotherapy for 10 subjects with chronic, treatment-resistant PTSD. The first subject was treated in April …
On May 13, 2014, the fourth subject was enrolled in our ongoing Israeli study of MDMA-assisted psychotherapy for 10 subjects with chronic, treatment-resistant PTSD. The subject prematurely reported last …
On January 7, 2014, MAPS Clinical Research Associate Mimi Peleg completed the regularly scheduled site monitoring visit for our ongoing Israeli study of MDMA-assisted psychotherapy for PTSD. The study …
On January 2, 2014, the third subject received their second experimental treatment in our ongoing Israeli study of MDMA-assisted psychotherapy for 10 subjects with chronic, treatment-resistant PTSD. The …
On November 27, 2013, the third subject began treatment in our ongoing Israeli study of MDMA-assisted psychotherapy for 10 subjects with chronic, treatment-resistant PTSD. Goals for this study include …
Ongoing study Location: Beer Yaakov, Israel Clinical Investigator: Moshe Kotler, M.D. Estimated study budget: $463,000 Already raised: $39,000 Needed to complete this study: $423,000 …
On July 19 and 31, 2013, trained raters completed their evaluations of the video recordings for the first two subjects in our ongoing Israeli study of MDMA-assisted psychotherapy for subjects with chronic, …
On July 10, 2013, the second subject completed their last experimental treatment in our ongoing Israeli study of MDMA-assisted psychotherapy for chronic, treatment-resistant PTSD. Data collected from this …
On May 29, 2013, the second subject was enrolled in our ongoing Israeli study of treating PTSD with MDMA-assisted psychotherapy. This study, led by Clinical Investigator Moshe Kotler, M.D., at Beer Yaakov …
On April 17, 2013, the first subject was treated in our new Israeli study of MDMA-assisted psychotherapy for PTSD. This study will enroll 10 subjects with chronic, treatment-resistant PTSD, some of whom …
On February 12, 2013, the first subject was enrolled in our new Israeli study of MDMA-assisted psychotherapy for PTSD. This study will enroll 10 subjects with chronic, treatment-resistant PTSD, some of …
On January 17, 2013, the first subject completed in-person screening for our new Israeli study of MDMA-assisted psychotherapy for PTSD, led by Principal Investigator Moshe Kotler, M.D., and monitored by …